P/E ratio for Integra LifeSciences (IART)
P/E ratio as of April 2024 (TTM): 24.1
According to Integra LifeSciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.082. At the end of 2022 the company had a P/E ratio of 26.0.
P/E ratio history for Integra LifeSciences from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 26.0 | -22.66% |
| 2021 | 33.6 | -17.84% |
| 2020 | 40.9 | -58.75% |
| 2019 | 99.0 | 59.36% |
| 2018 | 62.2 | 8.54% |
| 2017 | 57.3 | 33.23% |
| 2016 | 43.0 | -102.97% |
| 2015 | < -1000 | -2888.61% |
| 2014 | 52.0 | -173.44% |
| 2013 | -70.7 | -366.29% |
| 2012 | 26.6 | -16.41% |
| 2011 | 31.8 | 49.17% |
| 2010 | 21.3 | 0.55% |
| 2009 | 21.2 | -40.43% |
| 2008 | 35.6 | 2.65% |
| 2007 | 34.7 | -18.64% |
| 2006 | 42.6 | 47.73% |
| 2005 | 28.8 | -55.5% |
| 2004 | 64.8 | 107.98% |
| 2003 | 31.2 | 113.56% |
| 2002 | 14.6 | -40.74% |
| 2001 | 24.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.6 | -55.91% | 🇺🇸 USA |
 Medtronic MDT | 29.9 | 24.10% | 🇮🇪 Ireland |
 Stryker Corporation SYK | 49.2 | 104.22% | 🇺🇸 USA |
 Teleflex TFX | 24.5 | 1.93% | 🇺🇸 USA |
 Cardinal Health CAH | 102 | 324.99% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | -30.9 | -228.15% | 🇺🇸 USA |
 CONMED CNMD | 37.5 | 55.85% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.